[HTML][HTML] Cortical porosity occurs at varying degrees throughout the skeleton in rats with chronic kidney disease

CE Metzger, CL Newman, SP Tippen, NT Golemme… - Bone Reports, 2022 - Elsevier
Cortical porosity develops in chronic kidney disease (CKD) and increases with progressing
disease. Cortical porosity is likely a prominent contributor to skeletal fragility/fracture. The …

Phenotypic features of vascular calcification in chronic kidney disease

L Dai, M Debowska, T Lukaszuk… - Journal of internal …, 2020 - Wiley Online Library
Background Patients with chronic kidney disease stage 5 (CKD5) are predisposed to
vascular calcification (VC), but the combined effect of factors associated with VC was …

Inhibition of osteoclast differentiation by 1.25‐D and the calcimimetic KP2326 reveals 1.25‐D resistance in advanced CKD

J Bernardor, S Flammier, B Ranchin… - Journal of Bone and …, 2020 - academic.oup.com
Active vitamin D analogs and calcimimetics are the main therapies used for treating
secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) …

Kidney disease and bone: changing the way we look at skeletal health

MR Allen, EA Swallow, CE Metzger - Current osteoporosis reports, 2020 - Springer
Abstract Purpose of Review Kidney disease imparts profound skeletal changes, and unlike
many other skeletal diseases, cortical bone is predominantly impacted. Significant advances …

[图书][B] Interactions Between Aging and Chronic Kidney Disease on the Skeleton

SP Tippen - 2023 - search.proquest.com
In the US, 15% of adults have chronic kidney disease (CKD). While CKD occurs across all
ages, the prevalence is highest in the aged, with~ 40% of individuals over age 65 having …